logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

BupivacaineCompartment syndrome following an off-label use: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2017年 / 1644卷 / 1期
关键词:
D O I:
10.1007/s40278-017-27833-2
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:61 / 61
相关论文
共 50 条
  • [31] SirolimusPneumonia following off-label use: case report
    Reactions Weekly, 2020, 1800 (1) : 269 - 269
  • [32] ClonazepamMisidentification following off-label use: case report
    Reactions Weekly, 2022, 1926 (1) : 171 - 171
  • [33] RituximabAgranulocytosis following off-label use: case report
    Reactions Weekly, 2018, 1712 (1) : 482 - 482
  • [34] InsulinHypoglycaemia following off-label use: case report
    Reactions Weekly, 2021, 1843 (1) : 204 - 204
  • [35] GalcanezumabConstipation following off-label use: case report
    Reactions Weekly, 2025, 2046 (1) : 169 - 169
  • [36] BevacizumabCataract following off-label use: case report
    Reactions Weekly, 2019, 1747 (1) : 63 - 63
  • [37] SirolimusNeutropenia following off-label use: case report
    Reactions Weekly, 2023, 1960 (1) : 394 - 394
  • [38] RisperidonePancreatitis following off-label use: case report
    Reactions Weekly, 2022, 1934 (1) : 378 - 378
  • [39] TemozolomideThrombocytopenia following off-label use: case report
    Reactions Weekly, 2025, 2040 (1) : 934 - 934
  • [40] CyclophosphamideMyelosuppression following off-label use: case report
    Reactions Weekly, 2020, 1835 (1) : 116 - 116
← 12345 →